| Date | Title | Description |
| 18.03.2026 | Ternary Therapeutics: €4.1 Million Raised For AI-Driven Molecular Glue Drug Discovery Platform | Ternary Therapeutics, a London-based biotechnology company, has raised €4.1 million (£3.6 million) in a seed funding round to advance its artificial intelligence-powered platform for drug discovery. The round was led by daphni, with partici... |
| 16.03.2026 | Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million | London-based BioTech startup Ternary Therapeutics has raised €4.1 million (£3.6 million) in Seed funding to scale an AI platform designed to create a new class of medicines known as molecular glues.
The round was led by European venture fir... |
| 11.03.2026 | Spotlight Pathology has raised £1.4M to catch blood cancer sooner | Spotlight Pathology, a UK healthtech company, has raised £1.4 million in seed investment to support its development of AI software that analyses digital pathology images to support clinicians in identifying blood cancers faster and consiste... |
| 10.03.2026 | Cytotrait Secures £3M: Revolutionizing Crop Traits with MOSS Gene-Editing | Cytotrait, a cutting-edge biotech firm, secured £3M in seed funding. This capital fuels the advancement of their MOSS technology. MOSS is a proprietary plant gene-editing platform. It precisely modifies chloroplasts and mitochondria. This i... |
| 10.03.2026 | Cytotrait: £3 Million Seed Funding Raised For Crop Engineering Technology | Cytotrait, a biotechnology spinout from The University of Manchester focused on developing novel traits for food and agriculture, has secured £3 million in seed funding to advance its crop engineering platform and expand research across maj... |
| 09.03.2026 | Cytotrait Raises £3M in Seed Funding | Cytotrait, a Manchester, UK-based biotechnology company focused on the development of novel traits for food and agriculture, closed £3M seed funding round.
The investment was led by Northern Gritstone, with contributions from the UK Innovat... |
| 09.03.2026 | Cytotrait raises £3M for agricultural gene-editing technology | Cytotrait, a spinout from The University of Manchester focused on developing new traits for food and agricultural applications, has closed a £3 million seed funding round. The round was led by Northern Gritstone, with participation from the... |
| 31.10.2025 | CustoMED Expands Global Reach with $6M Investment in AI-Driven Orthopedic Care | Israeli healthtech company CustoMED has completed its seed funding round, bringing total funding to $6 million. The round includes participation from Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority,... |
| 24.10.2025 | Astut, an Oxford University spin-out, lands €1.8 million round for transparent reasoning-based AI | Astut, an AI startup spun out of Oxford University mathematics research, today announces €1.8 million in Seed funding to commercialise its breakthrough technology that helps organisations navigate unprecedented crises where traditional AI s... |
| 10.09.2025 | From orbit to farm: London’s Messium scores €3.8 million to transform how the world feeds itself | Messium, a UK AgriTech innovator using hyperspectral satellites and AI-driven crop growth models to tackle the challenge of nitrogen efficiency in farming, has secured a €3.8 million Seed investment.
The round was co-led by the UK Innovatio... |
| 08.09.2025 | Maeving Raises £11M in Series A Funding | Maeving, a Coventry, UK-based electric motorcycle company, raised £11M in Series A funding.
Backers included Venrex, Future Planet Capital and Elbow Beach alongside angel investors such as John Ayton MBE and Simon Hill-Norton.
The company i... |
| 19.08.2025 | Oxford-based SugaROx secured €1.1 million to accelerate the development and production of its crop-enhancing biostimulants | SugaROx, an Oxford-based agri-biotech spinout, has secured an additional €1.1 million (£1 million) in a seed round extension to accelerate the development and production of its crop-enhancing biostimulant, targeting improvements in food pro... |
| 25.07.2025 | Eyes on the skies: London’s Spaceflux secures €6.1 million to scale satellite-tracking network | SpaceTech startup Spaceflux has raised €6.1 million in Seed funding to accelerate the deployment of its global telescope network and enhance its AI-powered space situational awareness (SSA) technology.
The round was co-led by the UK Innovat... |
| 25.07.2025 | Spaceflux raises £5.4M to boost growth in space domain awareness sector | Spaceflux, headquartered in London, has successfully closed a £5.4 million seed funding round, enabling the company to fast-track the growth of its proprietary global telescope network and push forward innovative space situational awareness... |
| 15.07.2025 | British startup Cryogenx raises €1.9 million to tackle deadly heat stress in military and industry | London-based Cryogenx has raised €1.9 million as part of Seed funding round to accelerate the development of its portable cooling technology to combat heat strokes.
The UK Innovation & Science Seed Fund (UKI2S), managed by Future Planet... |
| 30.10.2024 | Bendi: Pioneering Supply Chain Transparency in a Complex World | In the intricate web of global commerce, supply chains are the lifeblood of businesses. Yet, they often resemble a dark forest, filled with hidden dangers and unseen paths. Enter Bendi, a London-based startup that has just secured €960,000 ... |
| 30.10.2024 | Bendi raises $1.04M to secure supply chain risk management | Predictive data intelligence platform Bendi announced today that it has raised $1.04 million in Pre-Seed funding.
Bendi is an AI-powered platform that helps businesses identify, analyse and manage ESG risks in complex global supply chains.
... |
| 21.03.2024 | AI-driven sepsis and infection tests rolled out to NHS with £1.5m funding | A UK start-up has employed the power of artificial intelligence to help enhance the diagnosis of sepsis.
Sepsis is a severe and potentially fatal condition caused by infection, usually leading to organ failure. A significant number of survi... |
| 24.07.2023 | Treasury Committee: Tax Scheme Limitation Disadvantages Regional Startups | According to a new Treasury Committee report, the UK’s venture capital-focused tax relief schemes having a seven-to-10 year business “age limit” is disadvantageous to startups in regions outside the “Golden Triangle.”
The recently published... |
| 30.11.2022 | Venture Partner Priya Guha MBE joins the Investment Governance Board of Future Planet Capital | Merian Ventures is delighted to announce that Venture Partner Priya Guha MBE has joined the Investment Governance Board of Future Planet Capital. Priya joins existing Future Planet Capital Investment Governance Board members Paul Abberley, ... |
| 21.04.2022 | Newcastle’s AMLo gets £2.45 million-shot to facilitate early-stage skin cancer test | UK-based medical device company that specialises in the early detection of skin cancers, AMLo Biosciences (AMLo) has brought in an investment of £2.45 million. The round saw the participation of Ascension’s Life Fund and Conduit’s EIS Impac... |
| 23.03.2022 | Changing the tide! London-based VC firm makes waves with €20 million fund to back startups supporting ocean health | London- headquartered venture capital and impact investor Future Planet Capital has wrapped up a €20 million fund to tackle key issues affecting the world’s oceans. Dubbed the ‘Blue Ocean mandate’, the fund will look at investing in ten to ... |
| 03.02.2022 | Nuclera raises $42.5M in first close of Series B for desktop protein printer | Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, announces that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and co... |
| 03.02.2022 | Nuclera raises $42.5M in first close of Series B for desktop protein printer | Nuclera raises $42.5M in first close of Series B for desktop protein printer
03-02-2022
Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, announces that the first close of its Series B financing has ... |
| 02.02.2022 | UK biotech startup ropes in $42.5 million to create 3D protein printer | Biotech company developing cutting-edge benchtop protein printing technologies, Nuclera has raised $42.5 million funding in Series B. The round saw the participation of new and existing institutional and strategic investors, including M&... |
| 02.02.2022 | Nuclera raises $42.5M towards launch of new protein 3D printer that “makes drug discovery accessible” | Insiders and analysts have made their predictions on the 3D printing trends to watch out for. Find out more in our series focused on the future of 3D printing.
Biotechnology start-up Nuclera has raised $42.5 million towards the launch of a ... |
| 24.01.2022 | Future Planet Capital, the Impact-led VC Firm for High-Growth Businesses, Launches Funding Campaign via Seedrs | Future Planet Capital, the impact-led, international VC company built to invest in high-growth firms from the world’s leading universities and research centers, has sold £18,549 with 26 days left in its campaign carried out via Seedrs.
Futu... |
| 16.12.2021 | UK Scaleup Navenio Secures $12.6M Investment to Accelerate Global Growth in Healthcare and Beyond | Oxford University spin-out’s indoor location-based platform adds to last year’s $11M Series A investment to improve workforce efficiency in healthcare and other verticals
The Oxford Science Enterprises-led round will support expansion in th... |
| 28.11.2021 | Future Planet Capital Acquires £2.7M+ from 412 Investors via Seedrs | Future Planet Capital, an impact-led, global VC company launched to invest in high-growth firms the world’s leading universities and research centers, has raised 111% (£2,777,247) of its £2,500,065 target from 412 investors (at the time of ... |
| 06.02.2018 | Chinese funds plow cash into British VC shops
W h i t e p a p e r
Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Chinese investors are set to pump money into two British funds. The agreements stand to create investment vehicles with more than $1 billion (€810 million) under management and an interest in bringing British innovations to China.
Sponsored... |
| 06.02.2018 | Chinese funds plow cash into British VC shops | Chinese investors are set to pump money into two British funds. The agreements stand to create investment vehicles with more than $1 billion (€810 million) under management and an interest in bringing British innovations to China.
Eight Gre... |
| 26.05.2017 | PragmatIC named Future Planet 'Company of the Year' | PragmatIC named Future Planet 'Company of the Year'
26-05-2017
PragmatIC is proud to be the winner of the 2017 Future Planet Awards. This prestigious award recognises the potential for PragmatIC to change the world with its unique approach ... |
| - | Future Planet Capital acquires Milltrust Agricultural Investments and RT Capital | London-based, but Cayman Islands registered Future Planet Capital has announced the acquisition of Milltrust Agricultural Investments and RT Capital, effectively bringing $130 million more to Future Planet’s table and taking the total asset... |
| - | UKI2S expands fund by £37 million to speed up British innovation | The UK Innovation and Science Seed Fund (UKI2S ) has expanded its patient capital fund by £37 million. The early-stage investment fund will support the most ambitious UK-based innovators at seed and beyond to facilitate sustainable growth, ... |
| - | Changing the tide! London-based VC firm makes waves with €20 million fund to back startups supporting ocean health | London- headquartered venture capital and impact investor Future Planet Capital has wrapped up a €20 million fund to tackle key issues affecting the world’s oceans. Dubbed the ‘Blue Ocean mandate’, the fund will look at investing in ten to ... |
| - | UK biotech startup ropes in $42.5 million to create 3D protein printer | Biotech company developing cutting-edge benchtop protein printing technologies, Nuclera has raised $42.5 million funding in Series B. The round saw the participation of new and existing institutional and strategic investors, including M&... |
| - | Newcastle’s AMLo gets £2.45 million-shot to facilitate early-stage skin cancer test | UK-based medical device company that specialises in the early detection of skin cancers, AMLo Biosciences (AMLo) has brought in an investment of £2.45 million. The round saw the participation of Ascension’s Life Fund and Conduit’s EIS Impac... |
